537 related articles for article (PubMed ID: 29021890)
1. Zebrafish knockout of Down syndrome gene,
Kim OH; Cho HJ; Han E; Hong TI; Ariyasiri K; Choi JH; Hwang KS; Jeong YM; Yang SY; Yu K; Park DS; Oh HW; Davis EE; Schwartz CE; Lee JS; Kim HG; Kim CH
Mol Autism; 2017; 8():50. PubMed ID: 29021890
[TBL] [Abstract][Full Text] [Related]
2. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
[TBL] [Abstract][Full Text] [Related]
3. DYRK1A mutations in two unrelated patients.
Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
[TBL] [Abstract][Full Text] [Related]
4. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
[TBL] [Abstract][Full Text] [Related]
5. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
van Bon BW; Coe BP; Bernier R; Green C; Gerdts J; Witherspoon K; Kleefstra T; Willemsen MH; Kumar R; Bosco P; Fichera M; Li D; Amaral D; Cristofoli F; Peeters H; Haan E; Romano C; Mefford HC; Scheffer I; Gecz J; de Vries BB; Eichler EE
Mol Psychiatry; 2016 Jan; 21(1):126-32. PubMed ID: 25707398
[TBL] [Abstract][Full Text] [Related]
6. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.
Ji J; Lee H; Argiropoulos B; Dorrani N; Mann J; Martinez-Agosto JA; Gomez-Ospina N; Gallant N; Bernstein JA; Hudgins L; Slattery L; Isidor B; Le Caignec C; David A; Obersztyn E; Wiśniowiecka-Kowalnik B; Fox M; Deignan JL; Vilain E; Hendricks E; Horton Harr M; Noon SE; Jackson JR; Wilkens A; Mirzaa G; Salamon N; Abramson J; Zackai EH; Krantz I; Innes AM; Nelson SF; Grody WW; Quintero-Rivera F
Eur J Hum Genet; 2015 Nov; 23(11):1473-81. PubMed ID: 25944381
[TBL] [Abstract][Full Text] [Related]
7. Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling.
Levy JA; LaFlamme CW; Tsaprailis G; Crynen G; Page DT
Biol Psychiatry; 2021 Sep; 90(5):295-306. PubMed ID: 33840455
[TBL] [Abstract][Full Text] [Related]
8. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
9. DYRK1A-haploinsufficiency in mice causes autistic-like features and febrile seizures.
Raveau M; Shimohata A; Amano K; Miyamoto H; Yamakawa K
Neurobiol Dis; 2018 Feb; 110():180-191. PubMed ID: 29223763
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome-associated kinase Dyrk1A overexpression.
Buchberger A; Schepergerdes L; Flaßhoff M; Kunick C; Köster RW
J Biol Chem; 2021 Jul; 297(1):100853. PubMed ID: 34090874
[TBL] [Abstract][Full Text] [Related]
11. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.
Møller RS; Kübart S; Hoeltzenbein M; Heye B; Vogel I; Hansen CP; Menzel C; Ullmann R; Tommerup N; Ropers HH; Tümer Z; Kalscheuer VM
Am J Hum Genet; 2008 May; 82(5):1165-70. PubMed ID: 18405873
[TBL] [Abstract][Full Text] [Related]
12. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
[TBL] [Abstract][Full Text] [Related]
13. Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome.
Arranz J; Balducci E; Arató K; Sánchez-Elexpuru G; Najas S; Parras A; Rebollo E; Pijuan I; Erb I; Verde G; Sahun I; Barallobre MJ; Lucas JJ; Sánchez MP; de la Luna S; Arbonés ML
Neurobiol Dis; 2019 Jul; 127():210-222. PubMed ID: 30831192
[TBL] [Abstract][Full Text] [Related]
14. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
Çağlayan ES
Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of DYRK1A, a Down Syndrome Candidate gene, Impairs Primordial Germ Cells Maintenance and Migration in zebrafish.
Liu Y; Lin Z; Liu M; Wang H; Sun H
Sci Rep; 2017 Nov; 7(1):15313. PubMed ID: 29127398
[TBL] [Abstract][Full Text] [Related]
16. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
[TBL] [Abstract][Full Text] [Related]
17. Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice.
Yin X; Jin N; Shi J; Zhang Y; Wu Y; Gong CX; Iqbal K; Liu F
Sci Rep; 2017 Apr; 7(1):619. PubMed ID: 28377597
[TBL] [Abstract][Full Text] [Related]
18. Vascular defects of
Cho HJ; Lee JG; Kim JH; Kim SY; Huh YH; Kim HJ; Lee KS; Yu K; Lee JS
Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31043432
[No Abstract] [Full Text] [Related]
19. Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a.
Marechal D; Brault V; Leon A; Martin D; Lopes Pereira P; Loaëc N; Birling MC; Friocourt G; Blondel M; Herault Y
Hum Mol Genet; 2019 May; 28(9):1561-1577. PubMed ID: 30649339
[TBL] [Abstract][Full Text] [Related]
20. Targeted knockout of a chemokine-like gene increases anxiety and fear responses.
Choi JH; Jeong YM; Kim S; Lee B; Ariyasiri K; Kim HT; Jung SH; Hwang KS; Choi TI; Park CO; Huh WK; Carl M; Rosenfeld JA; Raskin S; Ma A; Gecz J; Kim HG; Kim JS; Shin HC; Park DS; Gerlai R; Jamieson BB; Kim JS; Iremonger KJ; Lee SH; Shin HS; Kim CH
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E1041-E1050. PubMed ID: 29339520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
